Electronegative LDL [LDL(-)] had 5-fold higher platelet-activating factor acetylhydrolase activity than nonelectronegative LDL [LDL(+)] in normolipemic and hypercholesterolemic subjects.
Observational
Is platelet-activating factor acetylhydrolase (PAF-AH) activity higher in electronegative LDL compared to nonelectronegative LDL?
PAF-AH is predominantly associated with the electronegative LDL subfraction, which may contribute to its proinflammatory activity on endothelial cells.
Effect estimate: 5-fold higher
BACKGROUND: Electronegative LDL LDL(-), a modified subfraction of LDL present in plasma, induces the release of interleukin-8 and monocyte chemotactic protein-1 from cultured endothelial cells. METHODS AND RESULTS: We demonstrate that platelet-activating factor acetylhydrolase (PAF-AH) is mainly associated with LDL(-). LDL(-) had 5-fold higher PAF-AH activity than the nonelectronegative LDL subfraction LDL(+) in both normolipemic and familial hypercholesterolemic subjects. Western blot analysis after SDS-PAGE confirmed these results, because a single band of 44 kDa corresponding to PAF-AH appeared in LDL(-) but not in LDL(+). Nondenaturing polyacrylamide gradient gel electrophoresis demonstrated that PAF-AH was bound to LDL(-) regardless of LDL size. In accordance with the above findings, nonesterified fatty acids, a cleavage product of PAF-AH, were increased in LDL(-) compared with LDL(+). CONCLUSIONS: The high PAF-AH activity observed in LDL(-) could be related to the proinflammatory activity of these lipoproteins toward cultured endothelial cells.
Benı́tez et al. (Tue,) conducted a observational in Normolipemia and familial hypercholesterolemia. Electronegative LDL [LDL(-)] vs. Nonelectronegative LDL subfraction [LDL(+)] was evaluated on PAF-AH activity (5-fold higher). Electronegative LDL [LDL(-)] had 5-fold higher platelet-activating factor acetylhydrolase activity than nonelectronegative LDL [LDL(+)] in normolipemic and hypercholesterolemic subjects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: